Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB

C. U. Köser, J. Robledo, N. Shubladze, T. Schön, D. L. Dolinger, Max Salfinger

    Research output: Contribution to journalReview articlepeer-review

    2 Scopus citations
    Original languageEnglish
    Pages (from-to)791-794
    Number of pages4
    JournalInternational Journal of Tuberculosis and Lung Disease
    Volume25
    Issue number10
    DOIs
    StatePublished - 1 Oct 2021

    Bibliographical note

    Funding Information:
    CUK received an observership by the European Society of Clinical Microbiology and Infectious Diseases. JR is funded by Ministerio de Ciencia Tecnolog?a e Innovaci?n, Bogot?, Colombia (No. 221389666216 CT-783-2018). CUK is a research associate at Wolfson College, University of Cambridge, and visiting scientist at the Department of Genetics, University of Cambridge, Cambridge, UK. TS is funded by the Swedish Heart and Lung Foundation, Stockholm, and the Swedish Research Council, Stockholm, Sweden. Conflicts of interest: CUK's consulting work for Becton Dickinson involves a collaboration with Janssen, Beerse, Belgium; and Thermo Fisher Scientific, Waltham, MA, USA. CUK also consults for the Foundation for Innovative New Diagnostics, Geneva, Switzerland; and the TB Alliance, New York, NY, USA. CUK worked as a consultant for QuantuMDx, Newcastle upon Tyne, UK; the Stop TB Partnership, Geneva, Switzerland; the WHO Global TB Programme, Geneva, Switzerland; and the WHO Regional Office for Europe, Copenhagen, Denmark. CUK gave a paid educational talk for Oxford Immunotec, Abingdon, UK. Hain Lifescience covered CUK's travel and accommodation to present at a meeting. CUK is an unpaid advisor to BioVersys, Basel, Switzerland; and GenoScreen, Lille, France. JR gave a paid talk for bioM?rieux, Marcy l'Etoile, France, and received funding from BD, Franklin Lakes, NJ, USA. DLD works for PhAST, Cambridge, MA, USA. DLD also provides consulting services for Molbio Diagnostics, Verna, India; Partners in Health, Boston, MA, USA; and M?decins Sans Fronti?res, Paris, France. DLD worked for QuantuMDx.

    Funding Information:
    CUK received an observership by the European Society of Clinical Microbiology and Infectious Diseases. JR is funded by Ministerio de Ciencia Tecnología e Innovación, Bogotà, Colombia (No. 221389666216 CT-783-2018). CUK is a research associate at Wolfson College, University of Cambridge, and visiting scientist at the Department of Genetics, University of Cambridge, Cambridge, UK. TS is funded by the Swedish Heart and Lung Foundation, Stockholm, and the Swedish Research Council, Stockholm, Sweden.

    Cite this